4 years ago

[ASAP] Artatrovirenols A and B: Two Cagelike Sesquiterpenoids from Artemisia atrovirens

[ASAP] Artatrovirenols A and B: Two Cagelike Sesquiterpenoids from Artemisia atrovirens
Li-Hua Su, Chang-An Geng, Tian-Ze Li, Yun-Bao Ma, Xiao-Yan Huang, Xue-Mei Zhang, Ji-Jun Chen
Artatrovirenols A and B (1 and 2), two novel cagelike sesquiterpenoids, possess a unique 5/5/6/5/5-pentacyclic and a 5/5/6/5-tetracyclic system with an unprecedented tetracyclo[5.3.1.1.4,1101,5]dodecane scaffold from Artemisia atrovirens. The structures of compounds 1 and 2 including their absolute stereochemistry were elucidated through extensive spectroscopic analyses, X-ray crystallography, and quantum chemical calculations. Plausible biosynthetic pathways for the new isolates were proposed from the naturally occurring arglabin (3) via the key intramolecular Diels–Alder cycloaddition. Compound 1 showed cytotoxicity against three human hepatoma cell lines (HepG2, SMMC-7721, and Huh7) with half maximal inhibitory concentration values of 123.8, 44.0, and 142.6 μΜ, respectively. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.joc.0c01491. 1D and 2D NMR, HRESIMS, IR, [α]D, and CD spectra and bioassay (PDF) Crystallographic data of 1 (CIF) This article has not yet been cited by other publications.
You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.